NORTH CAROLINA, N.C. (AP) _ Aerie Pharmaceuticals Inc. (AERI) on Thursday reported a loss of $35.9 million in its first quarter.The North Carolina, North Carolina-based company said it had a loss of 76 cents per share. Losses, adjusted for non-recurring costs, were 66 cents per share.The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 65 cents per share.The drugmaker posted revenue of $29.8 million in the period, which also fell short of Street forecasts. Five analysts surveyed by Zacks expected $30.2 million.Aerie shares have climbed 10% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $7.72, a decrease of 54% in the last 12 months._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AERI at https://www.zacks.com/ap/AERI